Soros Fund Management’s AbbVie ABBV Stock Holding History

Soros Fund Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-165,000	Closed	-$7.38M	–	238
2013 Q3	$7.38M	Hold	165,000	–	–	0.08%	141
2013 Q2	$6.82M	Buy	+165,000	New	+$7.22M	0.07%	141

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

Soros Fund Management's ABBV Position: Q4 2014 in Review

Soros Fund Management sold out of AbbVie (ABBV) in Q4 2014, closing a stake of 1,537,146 shares — an estimated $88.8M sold.

Soros Fund Management first reported a position in ABBV in Q2 2013 and held it in 6 quarters. The position peaked at $88.8M in Q3 2014. 1,606 funds tracked by Wall St. Rank hold ABBV as of Q4 2014.

Soros Fund Management reported no remaining AbbVie position as of Q4 2014 after selling out during the quarter.
Soros Fund Management sold 1,537,146 AbbVie shares in Q4 2014, an estimated $88.8M.
Soros Fund Management first reported a position in AbbVie in Q2 2013 and held it in 6 quarters.
Soros Fund Management's AbbVie position peaked at $88.8M in Q3 2014.
1,606 funds tracked by Wall St. Rank held AbbVie as of Q4 2014.

Based on Soros Fund Management's 13F filing for Q4 2014, filed 17 Feb 2015.